Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin

Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - continues to grow, with reports from the South American country saying its...

from NDTV News - Topstories https://ift.tt/3ymwpp4